Hai-Long Zheng

Henagliflozin monotherapy in patients with type 2 diabetes inadequately controlled on diet and exercise: A randomized, double‐blind, placebo‐controlled, phase 3 trial

G. Qin, Zi-lin Sun, Liujun Fu, 2021, Diabetes, obesity & metabolism.

Protective effect of D-(−)-quinic acid as food supplement in modulating AMP-activated protein kinase signalling pathway activation in HFD induced obesity

Q. Zeng, L. Du, Jie Dong, 2022, Human & experimental toxicology.